Orthostatic hypotension and chronic fatigue syndrome.
作者信息
Jay S J
出版信息
JAMA. 2001 Mar 21;285(11):1442-3.
PMID:11255416
Abstract
摘要
相似文献
1
Orthostatic hypotension and chronic fatigue syndrome.
JAMA. 2001 Mar 21;285(11):1442-3.
2
Orthostatic hypotension and chronic fatigue syndrome.
JAMA. 2001 Mar 21;285(11):1442; author reply 1443.
3
Orthostatic hypotension and chronic fatigue syndrome.
JAMA. 2001 Mar 21;285(11):1441-2; author reply 1443. doi: 10.1001/jama.285.11.1441.
4
Fludrocortisone and chronic fatigue syndrome.
N Z Med J. 2003 Aug 8;116(1179):U549.
5
Chronic fatigue syndrome and neurally mediated hypotension.
JAMA. 1996 Feb 7;275(5):359; author reply 360. doi: 10.1001/jama.275.5.359c.
6
Adding droxidopa to fludrocortisone or midodrine in a patient with neurogenic orthostatic hypotension and Parkinson disease.
Clin Auton Res. 2017 Jul;27(Suppl 1):29-31. doi: 10.1007/s10286-017-0434-6. Epub 2017 Jul 3.
7
Investigations of hydrocortisone and fludrocortisone in the treatment of chronic fatigue syndrome.
J Clin Endocrinol Metab. 1999 Jun;84(6):2263-4. doi: 10.1210/jc.84.6.2263-a.
8
Chronic fatigue syndrome and Addison's disease.
J Pediatr. 2003 Feb;142(2):217; author reply 217-8. doi: 10.1067/mpd.2003.55.
9
Fludrocortisone acetate to treat neurally mediated hypotension in chronic fatigue syndrome: a randomized controlled trial.
JAMA. 2001 Jan 3;285(1):52-9. doi: 10.1001/jama.285.1.52.
10
A preliminary placebo-controlled crossover trial of fludrocortisone for chronic fatigue syndrome.
Arch Intern Med. 1998 Apr 27;158(8):908-14. doi: 10.1001/archinte.158.8.908.
引用本文的文献
1
Fludrocortisone for orthostatic hypotension.
Cochrane Database Syst Rev. 2021 May 17;5(5):CD012868. doi: 10.1002/14651858.CD012868.pub2.
Zotero 插件